Nathalie Iannotti

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Long-term immune and epigenetic dysregulation following COVID-19.

Long-term immune and epigenetic dysregulation following COVID-19.

Journal: Clinical immunology (Orlando, Fla.)

Published: October 07, 2025

Reduced spike specific T-cell responses in COVID-19 vaccinated subjects undergoing SARS-CoV-2 breakthrough infection.

Reduced spike specific T-cell responses in COVID-19 vaccinated subjects undergoing SARS-CoV-2 breakthrough infection.

Journal: Frontiers in immunology

Published: June 30, 2025

Preliminary Evidence of Good Safety Profile and Outcomes of Early Treatment with Tixagevimab/Cilgavimab Compared to Previously Employed Monoclonal Antibodies for COVID-19 in Immunocompromised Patients.

Preliminary Evidence of Good Safety Profile and Outcomes of Early Treatment with Tixagevimab/Cilgavimab Compared to Previously Employed Monoclonal Antibodies for COVID-19 in Immunocompromised Patients.

Journal: Biomedicines

Published: April 24, 2023

Safety Profile and Outcomes of Early COVID-19 Treatments in Immunocompromised Patients: A Single-Centre Cohort Study.

Safety Profile and Outcomes of Early COVID-19 Treatments in Immunocompromised Patients: A Single-Centre Cohort Study.

Journal: Biomedicines

Published: July 24, 2022

Long-term positive effect of an educational antimicrobial stewardship program implemented in an Internal Medicine Department: a prospective analysis and a point prevalence survey on long-term effect.

Long-term positive effect of an educational antimicrobial stewardship program implemented in an Internal Medicine Department: a prospective analysis and a point prevalence survey on long-term effect.

Journal: Journal of chemotherapy (Florence, Italy)

Published: December 30, 2020

The importance of patients' case-mix for the correct interpretation of the hospital fatality rate in COVID-19 disease.

The importance of patients' case-mix for the correct interpretation of the hospital fatality rate in COVID-19 disease.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: July 30, 2020

Association between abdominal aortic calcifications, bone mineral density and vertebral fractures in a cohort of HIV-positive patients.

Association between abdominal aortic calcifications, bone mineral density and vertebral fractures in a cohort of HIV-positive patients.

Journal: Journal of the International AIDS Society

Published: November 15, 2014

Immunophenotype and function of CD38-expressing CD4+ and CD8+ T cells in HIV-infected patients undergoing suppressive combination antiretroviral therapy.

Immunophenotype and function of CD38-expressing CD4+ and CD8+ T cells in HIV-infected patients undergoing suppressive combination antiretroviral therapy.

Journal: The Journal of infectious diseases

Published: September 09, 2014

Comment on: residual viraemia does not influence 1 year virological rebound in HIV-infected patients with HIV RNA persistently below 50 copies/mL.

Comment on: residual viraemia does not influence 1 year virological rebound in HIV-infected patients with HIV RNA persistently below 50 copies/mL.

Journal: The Journal of antimicrobial chemotherapy

Published: June 09, 2012

Migration patterns of HIV-1 subtype B virus in Northern Italy.

Migration patterns of HIV-1 subtype B virus in Northern Italy.

Journal: The new microbiologica

Published: June 07, 2012

Ultrasensitive assessment of residual low-level HIV viremia in HAART-treated patients and risk of virological failure.

Ultrasensitive assessment of residual low-level HIV viremia in HAART-treated patients and risk of virological failure.

Journal: Journal of acquired immune deficiency syndromes (1999)

Published: April 07, 2012

Immune reconstitution in HIV+ subjects on lopinavir/ritonavir-based HAART according to the severity of pre-therapy CD4+.

Immune reconstitution in HIV+ subjects on lopinavir/ritonavir-based HAART according to the severity of pre-therapy CD4+.

Journal: Current HIV research

Published: March 27, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026